Covidien Appoints New Treasurer

Dublin, Ireland-based Covidien has appointed Gregory S. Andrulonis vice president and treasurer of the company. He will assume responsibilities immediately.

Andrulonis succeeds Kevin G. DaSilva, who will remain vice president and group chief financial officer. He will be responsible for finance activities in Covidien’s respiratory and monitoring solutions and vascular therapies global business units, as well the company’s businesses in Japan, Australia, New Zealand and Canada, a position he has held since July 2011. DaSilva served as treasurer of the company since June 2007, when Covidien separated from Tyco International and became an independent company.

Andrulonis previously served as vice president and assistant treasurer of capital planning and markets, responsible for all aspects of Covidien’s capital markets, capital planning and credit functions. This included equity and debt financing activities in the financial markets, capital planning and structure, interest rate and foreign exchange rate risk management, global credit and collections and retirement plan investments. He held this position since it was created in June 2007.

Before Covidien became its own company, Andrulonis was the director of capital markets for Tyco International. Prior to joining Tyco, he worked at Lucent Technologies as regional treasurer for Latin America, and he held several positions of increasing responsibility in treasury, credit and banking earlier in his career.

He holds a bachelor’s degree from La Salle University and a master’s degree in finance from Temple University. Both universities are located in Philadelphia, Pennsylvania.

Covidien’s three core product segments are medical devices, pharmaceuticals and medical supplies. The company has been very acquisitive lately, expanding globally. Its United Stated headquarters are in Mansfield, Mass.